Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: PARATHYROID HORMONE, . Treffer: 90

2023

Zittermann, A; Pilz, S; Morshuis, M; Gummert, F; Milting, H Vitamin D deficiency and driveline infection in patients with a left ventricular assist device implant.
Int J Artif Organs. 2023; 46(4):235-240 Doi: 10.1177/03913988231154939
Web of Science PubMed FullText FullText_MUG

 

2022

Dimai, HP; Fahrleitner-Pammer, A Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions.
Best Pract Res Clin Rheumatol. 2022; 101780 Doi: 10.1016/j.berh.2022.101780
Web of Science PubMed FullText FullText_MUG

 

Ketteler, M; Wiecek, A; Rosenkranz, AR; Ose, C; Rekowski, J; Lorenz, H; Hellmann, B; Karus, M; Ruhmann, M; Ammer, R Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase III randomised controlled NOPHOS trial.
Nephrol Dial Transplant. 2022; Doi: 10.1093/ndt/gfac206 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pilz, S; Theiler-Schwetz, V; Pludowski, P; Zelzer, S; Meinitzer, A; Karras, SN; Misiorowski, W; Zittermann, A; März, W; Trummer, C Hypercalcemia in Pregnancy Due to CYP24A1 Mutations: Case Report and Review of the Literature.
Nutrients. 2022; 14(12): Doi: 10.3390/nu14122518 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Ketteler, M; Wiecek, A; Rosenkranz, AR; Pasch, A; Rekowski, J; Hellmann, B; Karus, M; Ammer, R Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial.
Kidney Int Rep. 2021; 6(3): 594-604. Doi: 10.1016/j.ekir.2020.12.012 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Nevola, KT; Kiel, DP; Zullo, AR; Weiss, S; Homuth, G; Foessl, I; Obermayer-Pietsch, B; Motyl, KJ; Lary, CW miRNA Mechanisms Underlying the Association of Beta Blocker Use and Bone Mineral Density.
J Bone Miner Res. 2021; 36(1):110-122 Doi: 10.1002/jbmr.4160 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Ewert, A; Leifheit-Nestler, M; Hohenfellner, K; Büscher, A; Kemper, MJ; Oh, J; Billing, H; Thumfart, J; Stangl, G; Baur, AC; Föller, M; Feger, M; Weber, LT; Acham-Roschitz, B; Arbeiter, K; Tönshoff, B; Zivicnjak, M; Haffner, D Bone and Mineral Metabolism in Children with Nephropathic Cystinosis Compared with other CKD Entities.
J Clin Endocrinol Metab. 2020; 105(8): Doi: 10.1210/clinem/dgaa267
Web of Science PubMed FullText FullText_MUG

 

Karras, SN; Koufakis, T; Antonopoulou, V; Goulis, DG; Annweiler, C; Pilz, S; Bili, H; Naughton, DP; Shah, I; Harizopoulou, V; Zebekakis, P; Bais, A; Kotsa, K Characterizing neonatal vitamin D deficiency in the modern era: a maternal-neonatal birth cohort from Southern Europe.
J Steroid Biochem Mol Biol. 2019; 105555-105555. Doi: 10.1016/j.jsbmb.2019.105555 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pérez-López, FR; Chedraui, P; Pilz, S Vitamin D supplementation after the menopause.
Ther Adv Endocrinol Metab. 2020; 11: 2042018820931291-2042018820931291. Doi: 10.1177/2042018820931291 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Giuliani, S; Barbieri, V; Di Pierro, AM; Rossi, F; Widmann, T; Lucchiari, M; Pusceddu, I; Pilz, S; Obermayer-Pietsch, B; Herrmann, M LC-MS/MS based 25(OH)D status in a large Southern European outpatient cohort: gender- and age-specific differences.
Eur J Nutr. 2019; 58(6):2511-2520 Doi: 10.1007/s00394-018-1803-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ursem, S; Francic, V; Keppel, M; Schwetz, V; Trummer, C; Pandis, M; Aberer, F; Grübler, MR; Verheyen, ND; März, W; Tomaschitz, A; Pilz, S; Obermayer-Pietsch, B; Heijboer, AC The effect of vitamin D supplementation on plasma non-oxidised PTH in a randomised clinical trial.
Endocr Connect. 2019; 8(5):518-527 Doi: 10.1530/EC-19-0097 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Friedl, C; Zitt, E Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy.
DRUG DES DEV THER. 2018; 12: 1589-1598. Doi: 10.2147/DDDT.S134103 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pilz, S; Trummer, C; Verheyen, N; Schwetz, V; Pandis, M; Aberer, F; Grübler, MR; Meinitzer, A; Bachmann, A; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; März, W; Obermayer-Pietsch, B; Tomaschitz, A Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.
Horm Metab Res. 2018; 50(5):375-382 Doi: 10.1055/a-0604-3249 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Swart, KM; Lips, P; Brouwer, IA; Jorde, R; Heymans, MW; Grimnes, G; Grübler, MR; Gaksch, M; Tomaschitz, A; Pilz, S; Eiriksdottir, G; Gudnason, V; Wamberg, L; Rejnmark, L; Sempos, CT; Durazo-Arvizu, RA; Dowling, KG; Hull, G; Škrabáková, Z; Kiely, M; Cashman, KD; van, Schoor, NM Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials.
Am J Clin Nutr. 2018; 107(6):1043-1053 Doi: 10.1093/ajcn/nqy078 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zittermann, A; Ernst, JB; Prokop, S; Fuchs, U; Dreier, J; Kuhn, J; Berthold, HK; Pilz, S; Gouni-Berthold, I; Gummert, JF Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.
Osteoporos Int. 2018; 29(3): 579-586. Doi: 10.1007/s00198-017-4312-9
Web of Science PubMed FullText FullText_MUG

 

2017

Fischer, V; Haffner-Luntzer, M; Prystaz, K; Vom Scheidt, A; Busse, B; Schinke, T; Amling, M; Ignatius, A Calcium and vitamin-D deficiency marginally impairs fracture healing but aggravates posttraumatic bone loss in osteoporotic mice.
Sci Rep. 2017; 7(1): 7223-7223. Doi: 10.1038/s41598-017-07511-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Frauscher, B; Artinger, K; Kirsch, AH; Aringer, I; Moschovaki-Filippidou, F; Kétszeri, M; Schabhüttl, C; Rainer, PP; Schmidt, A; Stojakovic, T; Fahrleitner-Pammer, A; Rosenkranz, AR; Eller, P; Eller, K A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder.
Int J Endocrinol. 2017; 2017(3):1659071-1659071 Doi: 10.1155/2017/1659071 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Friedl, C; Reibnegger, G; Kramar, R; Zitt, E; Pilz, S; Mann, JFE; Rosenkranz, AR Mortality in dialysis patients with cinacalcet use: A large observational registry study.
Eur J Intern Med. 2017; 42(5-6):89-95 Doi: 10.1016/j.ejim.2017.05.002
Web of Science PubMed FullText FullText_MUG

 

Hohenberger, G; Schwarz, A; Hartwig, E; Bücking, B [Teriparatide as a therapy approach in sacral insufficiency fractures].
Unfallchirurg. 2017; 120(11):1000-1003 Doi: 10.1007/s00113-017-0400-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jäger, MD; Serttas, M; Beneke, J; Müller, JA; Schrem, H; Kaltenborn, A; Ramackers, W; Ringe, BP; Gwiasda, J; Tränkenschuh, W; Klempnauer, J; Scheumann, GFW Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients.
PLoS One. 2017; 12(10): e0186093-e0186093. Doi: 10.1371/journal.pone.0186093 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pronai, W; Rosenkranz, AR; Bock, A; Klauser-Braun, R; Jäger, C; Pendl, G; Hemetsberger, M; Lhotta, K Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland - the observational TRANSIT Study.
Wien Klin Wochenschr. 2017; 129(9-10):317-328 Doi: 10.1007/s00508-016-1153-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Robinson-Cohen, C; Lutsey, PL; Kleber, ME; Nielson, CM; Mitchell, BD; Bis, JC; Eny, KM; Portas, L; Eriksson, J; Lorentzon, M; Koller, DL; Milaneschi, Y; Teumer, A; Pilz, S; Nethander, M; Selvin, E; Tang, W; Weng, LC; Wong, HS; Lai, D; Peacock, M; Hannemann, A; Völker, U; Homuth, G; Nauk, M; Murgia, F; Pattee, JW; Orwoll, E; Zmuda, JM; Riancho, JA; Wolf, M; Williams, F; Penninx, B; Econs, MJ; Ryan, KA; Ohlsson, C; Paterson, AD; Psaty, BM; Siscovick, DS; Rotter, JI; Pirastu, M; Streeten, E; März, W; Fox, C; Coresh, J; Wallaschofski, H; Pankow, JS; de Boer, IH; Kestenbaum, B Genetic Variants Associated with Circulating Parathyroid Hormone.
J Am Soc Nephrol. 2017; 28(5):1553-1565 Doi: 10.1681/ASN.2016010069 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ulbing, M; Kirsch, AH; Leber, B; Lemesch, S; Münzker, J; Schweighofer, N; Hofer, D; Trummer, O; Rosenkranz, AR; Müller, H; Eller, K; Stadlbauer, V; Obermayer-Pietsch, B MicroRNAs 223-3p and 93-5p in patients with chronic kidney disease before and after renal transplantation.
Bone. 2017; 95(4):115-123 Doi: 10.1016/j.bone.2016.11.016 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Verheyen, N; Fahrleitner-Pammer, A; Belyavskiy, E; Gruebler, MR; Dimai, HP; Amrein, K; Ablasser, K; Martensen, J; Catena, C; Pieske-Kraigher, E; Colantonio, C; Voelkl, J; Lang, F; Alesutan, I; Meinitzer, A; März, W; Brussee, H; Pieske, B; Pilz, S; Tomaschitz, A Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.
PLoS One. 2017; 12(4):e0173799-e0173799 Doi: 10.1371/journal.pone.0173799 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Verheyen, N; Grübler, MR; Meinitzer, A; Trummer, C; Schwetz, V; Amrein, K; Dimai, HP; März, W; Catena, C; von Lewinski, D; Voelkl, J; Alesutan, I; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.
Bone. 2017; 105(5):212-217 Doi: 10.1016/j.bone.2017.08.030
Web of Science PubMed FullText FullText_MUG

 

Verheyen, N; Meinitzer, A; Grübler, MR; Ablasser, K; Kolesnik, E; Fahrleitner-Pammer, A; Belyavskiy, E; Trummer, C; Schwetz, V; Pieske-Kraigher, E; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; Brussee, H; Lewinski, DV; März, W; Pieske, B; Pilz, S; Tomaschitz, A Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
Clin Chem Lab Med. 2017; 55(7):1034-1042 Doi: 10.1515/cclm-2016-1159
Web of Science PubMed FullText FullText_MUG

 

Wetzel, J; Pilz, S; Grübler, MR; Fahrleitner-Pammer, A; Dimai, HP; von Lewinski, D; Kolesnik, E; Perl, S; Trummer, C; Schwetz, V; Meinitzer, A; Belyavskiy, E; Völkl, J; Catena, C; Brandenburg, V; März, W; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, ND Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.
J Clin Hypertens (Greenwich). 2017; 19(11):1173-1180 Doi: 10.1111/jch.13064 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Haffner-Luntzer, M; Heilmann, A; Heidler, V; Liedert, A; Schinke, T; Amling, M; Yorgan, TA; Vom Scheidt, A; Ignatius, A Hypochlorhydria-induced calcium malabsorption does not affect fracture healing but increases post-traumatic bone loss in the intact skeleton.
J Orthop Res. 2016; 34(11): 1914-1921. Doi: 10.1002/jor.23221 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pilz, S; Putz-Bankuti, C; Gaksch, M; Spindelboeck, W; Haselberger, M; Rainer, F; Posch, A; Kreuzer, P; Stojakovic, T; Stadlbauer, V; Obermayer-Pietsch, B; Stauber, RE Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial.
Nutrients. 2016; 8(5): Doi: 10.3390/nu8050278 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tomaschitz, A; Verheyen, N; Meinitzer, A; Pieske, B; Belyavskiy, E; Brussee, H; Haas, J; März, W; Pieske-Kraigher, E; Verheyen, S; Ofner-Ziegenfuss, L; Hartaigh, BÓ; Schwetz, V; Aberer, F; Grübler, M; Lang, F; Alesutan, I; Voelkl, J; Gaksch, M; Horina, JH; Dimai, HP; Rus-Machan, J; Stiegler, C; Ritz, E; Fahrleitner-Pammer, A; Pilz, S Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
J Hypertens. 2016; 34(7):1347-56 Doi: 10.1097/HJH.0000000000000927
Web of Science PubMed FullText FullText_MUG

 

Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86 Doi: 10.1097/HJH.0000000000001004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Verheyen, ND; Kienreich, K; Gaksch, M; van, Ballegooijen, AJ; Grübler, MR; Hartaigh, BÓ; Schmid, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Colantonio, C; Belyavskiy, E; Treiber, G; Catena, C; Brussee, H; Pieske, B; März, W; Tomaschitz, A; Pilz, S Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2016; 18(6):543-50 Doi: 10.1111/jch.12710 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zittermann, A; Ernst, JB; Pilz, S; Dreier, J; Kuhn, J; Knabbe, C; Gummert, JF; Morshuis, M; Milting, H Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device.
PLoS One. 2016; 11(10):e0164459-e0164459 Doi: 10.1371/journal.pone.0164459 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zittermann, A; Morshuis, M; Kuhn, J; Pilz, S; Ernst, JB; Oezpeker, C; Dreier, J; Knabbe, C; Gummert, JF; Milting, H Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk.
Eur J Nutr. 2016; 55(1):305-313 Doi: 10.1007/s00394-015-0847-8
Web of Science PubMed FullText FullText_MUG

 

2015

Lerchbaum, E; Schwetz, V; Nauck, M; Völzke, H; Wallaschofski, H; Hannemann, A Lower bone turnover markers in metabolic syndrome and diabetes: the population-based Study of Health in Pomerania.
Nutr Metab Cardiovasc Dis. 2015; 25(5):458-463 Doi: 10.1016/j.numecd.2015.02.002
Web of Science PubMed FullText FullText_MUG

 

Pihlstrøm, H; Dahle, DO; Mjøen, G; Pilz, S; März, W; Abedini, S; Holme, I; Fellström, B; Jardine, AG; Holdaas, H Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.
Transplantation. 2015; 99(2):351-359 Doi: 10.1097/TP.0000000000000583 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tomaschitz, A; Pilz, S; Rus-Machan, J; Meinitzer, A; Brandenburg, VM; Scharnagl, H; Kapl, M; Grammer, T; Ritz, E; Horina, JH; Kleber, ME; Pieske, B; Kraigher-Krainer, E; Hartaigh, BÓ; Toplak, H; van Ballegooijen, AJ; Amrein, K; Fahrleitner-Pammer, A; März, W Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk.
Int J Cardiol. 2015; 184(9):710-716 Doi: 10.1016/j.ijcard.2015.03.062
Web of Science PubMed FullText FullText_MUG

 

Tomaschitz, A; Verheyen, N; Gaksch, M; Meinitzer, A; Pieske, B; Kraigher-Krainer, E; Colantonio, C; März, W; Schmidt, A; Belyavskiy, E; Rus-Machan, J; van, Ballegooijen, AJ; Stiegler, C; Amrein, K; Ritz, E; Fahrleitner-Pammer, A; Pilz, S Homoarginine in patients with primary hyperparathyroidism.
Am J Med Sci. 2015; 349(4):306-11 Doi: 10.1097/MAJ.0000000000000419
Web of Science PubMed FullText FullText_MUG

 

Verheyen, N; Wetzel, J; Martensen, J; Belyavskiy, E; Schmidt, A; Colantonio, C; Catena, C; Gaksch, M; Grübler, MR; Kraigher-Krainer, E; Pieske, B; Meinitzer, A; Rus-Machan, J; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A 9B.05: ASSOCIATION OF PLASMA PARATHYROID HORMONE WITH NIGHTTIME BLOOD PRESSURE IN PRIMARY HYPERPARATHYROIDISM-THE "EPLERENONE IN PRIMARY HYPERPARATHYROIDISM" TRIAL.
J Hypertens. . 2015; 33 Suppl 1(10):e121-e121. Doi: 10.1097/01.hjh.0000467677.24307.ad [Oral Communication]
Web of Science PubMed FullText FullText_MUG

 

2014

Amrein, K; Dobnig, H; Wagner, D; Piswanger-Sölkner, C; Pieber, TR; Pilz, S; Tomaschitz, A; Dimai, HP; Fahrleitner-Pammer, A Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.
J Am Geriatr Soc. 2014; 62(6):1023-1029 Doi: 10.1111/jgs.12791
Web of Science PubMed FullText FullText_MUG

 

Brandenburg, VM; Kleber, ME; Vervloet, MG; Tomaschitz, A; Pilz, S; Stojakovic, T; Delgado, G; Grammer, TB; Marx, N; März, W; Scharnagl, H Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Atherosclerosis. 2014; 237(1):53-59 Doi: 10.1016/j.atherosclerosis.2014.08.037
Web of Science PubMed FullText FullText_MUG

 

Tomaschitz, A; Ritz, E; Pieske, B; Rus-Machan, J; Kienreich, K; Verheyen, N; Gaksch, M; Grübler, M; Fahrleitner-Pammer, A; Mrak, P; Toplak, H; Kraigher-Krainer, E; März, W; Pilz, S Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Metabolism. 2014; 63(1):20-31 Doi: 10.1016/j.metabol.2013.08.016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Muhn, F; Klopocki, E; Graul-Neumann, L; Uhrig, S; Colley, A; Castori, M; Lankes, E; Henn, W; Gruber-Sedlmayr, U; Seifert, W; Horn, D Novel mutations of the PRKAR1A gene in patients with acrodysostosis.
Clin Genet. 2013; 84(6):531-538 Doi: 10.1111/cge.12106
Web of Science PubMed FullText FullText_MUG

 

Staude, H; Jeske, S; Schmitz, K; Warncke, G; Fischer, DC Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.
Kidney Blood Press Res. 2013; 37(1):68-83 Doi: 10.1159/000343402 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Verheyen, N; Pilz, S; Eller, K; Kienreich, K; Fahrleitner-Pammer, A; Pieske, B; Ritz, E; Tomaschitz, A Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
Expert Opin Pharmacother. 2013; 14(6):793-806 Doi: 10.1517/14656566.2013.777041
Web of Science PubMed FullText FullText_MUG

 

2012

Fernández-Rebollo, E; Maeda, A; Reyes, M; Turan, S; Fröhlich, LF; Plagge, A; Kelsey, G; Jüppner, H; Bastepe, M Loss of XLαs (extra-large αs) imprinting results in early postnatal hypoglycemia and lethality in a mouse model of pseudohypoparathyroidism Ib.
Proc Natl Acad Sci U S A. 2012; 109(17):6638-6643 Doi: 10.1073/pnas.1117608109 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Osto, E; Fallo, F; Pelizzo, MR; Maddalozzo, A; Sorgato, N; Corbetti, F; Montisci, R; Famoso, G; Bellu, R; Lüscher, TF; Iliceto, S; Tona, F Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.
Circulation. 2012; 126(9):1031-9 Doi: 10.1161/CIRCULATIONAHA.111.081307
Web of Science PubMed FullText FullText_MUG

 

Pilz, S; Kienreich, K; Stückler, D; Meinitzer, A; Tomaschitz, A Associations of Sun Exposure with 25-Hydroxyvitamin D and Parathyroid Hormone Levels in a Cohort of Hypertensive Patients: The Graz Endocrine Causes of Hypertension (GECOH) Study.
Int J Endocrinol. 2012; 2012(6):732636-732636 Doi: 10.1155/2012/732636 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tomaschitz, A; Fahrleitner-Pammer, A; Pieske, B; Verheyen, N; Amrein, K; Ritz, E; Kienreich, K; Horina, JH; Schmidt, A; Kraigher-Krainer, E; Colantonio, C; Meinitzer, A; Pilz, S Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.
BMC Endocr Disord. 2012; 12(12):19-19 Doi: 10.1186/1472-6823-12-19 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tomaschitz, A; Ritz, E; Pieske, B; Fahrleitner-Pammer, A; Kienreich, K; Horina, JH; Drechsler, C; März, W; Ofner, M; Pieber, TR; Pilz, S Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Cardiovasc Res. 2012; 94(1):10-19 Doi: 10.1093/cvr/cvs092 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum